Ocular Surface Disease and Eyelid Health: Seeing Eye to Eye

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by educational grants from Tarsus Pharmaceuticals, Inc. and Thea Pharma Inc.

Activity Description

The prevalence of ocular surface disease (OSD) continues to increase, but true prevalence figures are underestimated as the condition is commonly underdiagnosed. Several factors have been identified that increase the risk of OSD, including advanced age, certain medical conditions, history of contact lens wear, refractive surgery, and the chronic use of topical ophthalmic medications containing preservatives. The eyelid margin also plays an important role in the health and integrity of the ocular surface and the preocular tear film, and lid margin disease such as meibomian gland dysfunction or blepharitis can lead to OSD or dry eye disease (DED). Furthermore, patients with Demodex blepharitis may go undiagnosed or misdiagnosed due to overlapping symptoms seen in DED and other ocular surface or lid margin disorders. A myriad of treatments is now available for the management of conditions that negatively affect the ocular surface or lid margin, but a timely and accurate differential diagnosis and optimal treatment strategy is needed to resolve disease and improve patients’ quality-of-life measures. In this CE activity, experts in the field review patient assessment and evidence-based diagnostic techniques for the differential diagnosis of OSD and associated eyelid disorders and evaluate current and emerging treatment options that reduce these conditions.

Target Audience

The intended audience for this activity is ophthalmologists and other healthcare professionals involved in the management of patients with ocular surface disease (OSD) and associated eyelid disorders.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Assess patients for OSD and associated eyelid disorders, using evidence-based diagnostic modalities.
• Incorporate treatments that reduce OSD and associated eyelid disorders.

Activity Chair

Elizabeth Yeu, MD
Cornea, Cataract, External Disease and Refractive Surgery
Virginia Eye Consultants/EyeCare Partners
Assistant Professor, Eastern Virginia Medical School
President, American Society of Cataract and Refractive Surgery (ASCRS)
Norfolk, VA

Faculty

Penny Asbell, MD, MBA, FACS, FARVO
Clinical Professor of Ophthalmology
University of Tennessee Health Science Center
Memphis, TN

John D. Sheppard, MD, MMSc, FACS
President, Virginia Eye Consultants
Professor of Ophthalmology, Microbiology & Molecular Biology
Ophthalmology Residency Research Program Director
Eastern Virginia Medical School
Medical Director Lions Eye Bank of Eastern Virginia
Mid-Atlantic Medical Director, Eyecare Partners
Norfolk, VA

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, April 30, 2024, to April 29, 2025.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Penny Asbell, MD, MBA, FACS, FARVO
Consultant: Azura, Bausch + Lomb, Centricity, Glia, Glint, Harrow, Hindi, Horizon, Iolyx, NEI, PreMark, Regeneron, Senju, Trefoil

John D. Sheppard, MD, MMSc, FACS
Advisor: 1-800-DOCTORS, Alcon, Aldeyra, Allergan, ArcScan, Avedro, Bausch + Lomb, BioLayer, Bruder, Clearside, Clearview, Clementia Pharma, Dompé, Eyedetec, EyeGate, Eyevance, Glaukos, Hovione, Imprimis, Inspire/Merck, Isis Pharmaceuticals, Johnson & Johnson/TearScience/Vistakon, Kala, Kowa, LacriSciences, LayerBio, Lenstatin, Lux Biosciences, Mallinckrodt, Mati, Mitotech, Nicox, NovaBay, Novaliq, Novartis, Noveome/Stemnion, OcuCure, Oculis, Okogen, Omeros, Oyster Point, Parion, Portage, Quidel, RPS, Santen, Shire, Sun, Synedgen, Takeda, Talia Technology, TearLab, TopiVert
Consultant: AbbVie, Aldeyra, Allergan, Bausch + Lomb, Bio-Tissue/TissueTech, Clearside, Dompé, Eleven, Hovione, Johnson & Johnson/TearScience/Vistakon, Kowa, NovaBay, Noveome /Stemnion, Ocular Therapeutix, Quidel, Science Based Health, Sun, Surrozen, TearLab
Speaker Contracted by Ineligible Company: AbbVie, Alcon, Allergan, Avedro, Bausch + Lomb, Bio-Tissue/TissueTech, Dompé, Eleven, EyeGate, Inspire/Merck, Johnson & Johnson/TearScience/Vistakon, Lumenis, Mallinckrodt, NiCox, Novartis, Omeros, PentaVision, Pfizer, Santen, Science Based Health, Takeda, Talia Technology, TearLab, Topcon
Individual Stocks and Stock Options (publicly traded): NovaBay, Oyster Point
*Individual Stocks and Stock Options (privately held): 1-800-DOCTORS, Alphaeon (Parent company: Strathspey Crowne), BioLayer, Eyedetec, EyeGate Research, EyeRx Research, Eyevance, OcuHub, OcuCure, RPS, TearLab

Elizabeth Yeu, MD
Consultant: AbbVie, AcuFocus, Adaptilens, Advanced Vision, Aldeyra, Allergan, Aurion, Avellino, Bausch + Lomb, BioTissue, BlephEx, Bruder, BVI, Centricity, CorneaGen, Dompé, Elios, Expert Opinion, Eyenovia, Foresight, Glaukos, Guidepoint, IVERIC bio, Johnson & Johnson Vision, Kala, LayerBio, LENSAR, Melt, Merck, New World Medical, Novartis, Oculis, OCuSOFT, OSRX, Samsara, ScienceBased Health, Sight Sciences, STAAR, Surface, Tarsus, Théa, Visus, Zeiss
Speaker Contracted by Ineligible Company: Alcon, Virginia Eye Consultants/EyeCare Partners
Independent Research Contractor: AcuFocus, Alcon, BioTissue, New World Medical, Ocular Science, Tarsus
Individual Stocks (publicly traded): STAAR, Tarsus
*Individual Stocks (privately held): Aurion
Director: Avellino, STAAR, Tarsus

*Will not discuss business lines or products of company(ies).

Planner/Reviewer report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). To do so, kindly provide the following details:

• Specify the copyrighted work you believe has been infringed upon.
• Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
• Share your name, address, telephone number, and, if available, your email address.
• Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
• Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
• Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614

CE Questions?

Contact us at cme@vindicoCME.com